Literature DB >> 21034250

Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: II. Performance of a laboratory network running the HPLC candidate reference measurement procedure and evaluation of a candidate reference material.

Anders Helander1, Jos P M Wielders, Jan-Olof Jeppsson, Cas Weykamp, Carla Siebelder, Raymond F Anton, François Schellenberg, John B Whitfield.   

Abstract

Carbohydrate-deficient transferrin (CDT) is a descriptive term used for a temporary change in the transferrin glycosylation profile caused by alcohol, and used as a biomarker of chronic high alcohol consumption. The use of an array of methods for measurement of CDT in various absolute or relative amounts, and sometimes covering different transferrin glycoforms, has complicated the comparability of results and caused confusion among medical staff. This situation prompted initiation of an IFCC Working Group on CDT standardization. This second publication of the WG-CDT covers the establishment of a network of reference laboratories running a high-performance liquid chromatography (HPLC) candidate reference measurement procedure, and evaluation of candidate secondary reference materials. The network laboratories demonstrated good and reproducible performance and thus can be used to assign target values for calibrators and controls. A candidate secondary reference material based on native human serum lyophilized with a cryo-/lyoprotectant to prevent protein denaturation was found to be commutable and stable during storage. A proposed strategy for calibration of different CDT methods is also presented. In an external quality assurance study involving 66 laboratories and covering the current routine CDT assays (HPLC, capillary electrophoresis and immunoassay), recalculation of observed results based on the nominal values for the candidate calibrator reduced the overall coefficient of variation from 18.9% to 5.5%. The logistics for distribution of reference materials and review of results were found to be functional, indicating that a full reference system for CDT may soon be available.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034250     DOI: 10.1515/CCLM.2010.322

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

1.  Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence.

Authors:  Raymond F Anton; Patricia K Latham; Konstantin E Voronin; Patrick K Randall; Sarah W Book; Michaela Hoffman; Joseph P Schacht
Journal:  Alcohol Clin Exp Res       Date:  2018-02-12       Impact factor: 3.455

2.  Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women.

Authors:  Ludmila N Bakhireva; Sandra Cano; William F Rayburn; Renate D Savich; Lawrence Leeman; Raymond F Anton; Daniel D Savage
Journal:  Alcohol Alcohol       Date:  2012-08-08       Impact factor: 2.826

3.  Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa.

Authors:  Judith A Hahn; Loren M Dobkin; Bernard Mayanja; Nneka I Emenyonu; Isaac M Kigozi; Stephen Shiboski; David R Bangsberg; Heike Gnann; Wolfgang Weinmann; Friedrich M Wurst
Journal:  Alcohol Clin Exp Res       Date:  2011-12-07       Impact factor: 3.455

4.  Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease.

Authors:  Scott H Stewart; Adrian Reuben; Raymond F Anton
Journal:  Alcohol Alcohol       Date:  2016-10-07       Impact factor: 2.826

5.  Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.

Authors:  Raymond F Anton; Patricia Latham; Konstantin Voronin; Sarah Book; Michaela Hoffman; James Prisciandaro; Emily Bristol
Journal:  JAMA Intern Med       Date:  2020-05-01       Impact factor: 21.873

6.  Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.

Authors:  Raymond F Anton; Konstantin E Voronin; Sarah W Book; Patricia K Latham; Patrick K Randall; Willam Bailey Glen; Michaela Hoffman; Joseph P Schacht
Journal:  Alcohol Clin Exp Res       Date:  2020-09-19       Impact factor: 3.455

7.  Comparative performance of biomarkers of alcohol consumption in a population sample of working-aged men in Russia: the Izhevsk Family Study.

Authors:  Helen McDonald; Svetlana Borinskya; Nikolay Kiryanov; Artyom Gil; Anders Helander; David A Leon
Journal:  Addiction       Date:  2013-07-05       Impact factor: 6.526

8.  Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers.

Authors:  Kevin J Fagan; Katharine M Irvine; Brett C McWhinney; Linda M Fletcher; Leigh U Horsfall; Lambro Johnson; Peter O'Rourke; Jennifer Martin; Ian Scott; Carel J Pretorius; Jacobus P J Ungerer; Elizabeth E Powell
Journal:  BMC Gastroenterol       Date:  2014-05-22       Impact factor: 3.067

9.  Effects of automated smartphone mobile recovery support and telephone continuing care in the treatment of alcohol use disorder: study protocol for a randomized controlled trial.

Authors:  James R McKay; David H Gustafson; Megan Ivey; Fiona McTavish; Klaren Pe-Romashko; Brenda Curtis; David A Oslin; Daniel Polsky; Andrew Quanbeck; Kevin G Lynch
Journal:  Trials       Date:  2018-01-30       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.